Diligence memo · auto-generated · as of July 3, 2026

Adhezion Biomedical Llc

Adhezion Biomedical Llc looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Adhezion Biomedical Llc operates in Other Health Care, based in WYOMISSING.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Adhezion Biomedical Llc has raised $10M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $3.1M on 2018-08-17.

Most recent recorded round closed around 2020-12-28.

Valuation (modeled)modeled

Provath models Adhezion Biomedical Llc at approximately $60M (range $2.5M–$414M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.68× the median modeled value of Seed Other Health Care companies in 2019–2021 (211 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 33 months.

Last raise 5.5 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 76% of Other Health Care peers (5377 compared).

Modeled value ranks above 70% of those peers.

Closest niche peers: Crossroads at Delta Memory, Noninvasix, Inc., CPIV Haven Holdings, LLC, Cane Ip Key Holdings, Llc, Hospi Corp.

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.